Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Liquid fibrin sealant - OMRIX Biopharmaceuticals

Drug Profile

Liquid fibrin sealant - OMRIX Biopharmaceuticals

Alternative Names: Evicel; Quixil

Latest Information Update: 13 Sep 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator OMRIX Biopharmaceuticals
  • Developer Ethicon; OMRIX Biopharmaceuticals
  • Class Acute-phase proteins; Adhesives; Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Serine endopeptidases
  • Mechanism of Action Fibrinogen replacements; Thrombin replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Surgical blood loss

Most Recent Events

  • 13 Sep 2017 No recent reports on development identified - Phase-II for Surgical blood loss in South Korea (Topical)
  • 27 May 2015 Ethicon plans a phase III trial for Surgical blood loss in USA, Australia, Belgium, Germany and United Kingdom (NCT02457546)
  • 17 Apr 2014 Registered for Surgical blood loss in New Zealand (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top